Comparison of in vitro drug-sensitivity of human granulocyte-macrophage progenitors from two different origins: Umbilical cord blood and bone marrow

Experimental Hematology

Volumn 27, Issue 11, 1999, Pages 1593-1598

  Gribaldo, Laura ^a   Casati, Silvia ^a   Castoldi, Anna F ^b   Pessina, Augusto ^c  

^a JOINT RESEARCH CENTRE   (Italy)

^b Ctro Ric Fondazione salvatore M   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Bone marrow cells; CFU GM; Clinical toxicology; Umbilical cord blood

Indexed keywords

9 METHOXYPYRAZOLOACRIDINE; ACRIDINE DERIVATIVE; DOXORUBICIN; DOXORUBICIN DERIVATIVE; FLAVOPIRIDOL; METHOXYMORPHOLINYLDOXORUBICIN; PACLITAXEL; TOPOTECAN; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; BLOOD TOXICITY; BONE MARROW; COLONY FORMATION; COLONY FORMING UNIT GM; CONCENTRATION RESPONSE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STEM CELL; UMBILICAL CORD BLOOD;

BONE MARROW CELLS; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; DRUG EVALUATION, PRECLINICAL; FETAL BLOOD; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; INTERLEUKIN-6; MACROPHAGES; STEM CELL FACTOR;

EID: 0032743678     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00107-1     Document Type: Article

References (28)

1. Deldar A, House RV, Wierda D (1995) Bone marrow colony-forming assays. In: Methods in immunotoxicology, vol I., 227.
2. Boorman G.A., Luster M.I., Dean J.H., Campbell M.L. Assessment of myelotoxicity caused by environmental chemicals. Environ Health Perspect. 43:1982;129.
3. Deldar A., Stevens C.E. Development and application of in vitro models of hematopoiesis to drug development. Toxicol Pathol. 21:1993;231.
4. Parchment R.E., Huang M., Erickson-Miller C.L. Roles for in vitro myelotoxicty tests in preclinical drug development and clinical trial planning. Toxicol Pathol. 21:1993;241.
5. Kalmanti M., Dainiak N., Martino J., Dewey M., Kulkarni V., Howard D. Correlation of clinical and in vitro erythropoietic responses to androgens in renal failure. Kidney Int. 22:1982;383.
6. Noble C., Sina J.F. Usefulness of the in vitro bone marrow colony-forming assay in cellular toxicology. In Vitro Toxicol. 6:1993;187.
7. Gribaldo L., Bueren J., Deldar P., Hokland P., Meredith C., Moneta D., Mosesso P., Parchment R., Parent-Massin D., Pessina A., San Roman J., Schoethers G. The use of in vitro systems for evaluating haematotoxicity. ATLA. 24:1996;211.
8. Piacibello W., Ferrero D., Sanavio F., Badoni R., Stacchini A., Sverino A., Aglietta M. Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors. Exp Hematol. 19:1991;1084.
9. Metcalf D. Clonal analysis of proliferation and differentiation of paired daughter cells. action of granulocyte-macrophage colony stimulating factors on granulo-macrophage precursors Proc Natl Acad Sci U S A. 77:1980;5327.
10. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 81:1993;2844.
11. Okada S., Nakauchi H., Nagayoshi K., Nakamura M., Miura Y., Suda T. Synergistic effect of IL-3 and IL-6 on higly enriched murine hemopoietic progenitors. Exp Hematol. 20:1992;546.
12. Deldar A., Stevens C.E., Zack P.M. Differential hematotoxicity by a nucleoside in progenitor cell assays from the rat, dog, non-human primates and human. Vet Pathol. 32:1995;546.
13. Dainiak N., Worthington M., Riorden M.A., Kreczko S., Goldman L. 3'Azido-3' deoxythimidine (AZT) inhibits the proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol. 69:1988;299.
14. Fritsch G., Stimpfl M., Kurz M., Printz D., Buchinger P., Fischmeister G., Hoecker P., Gadner H. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Bone Marrow Transplant. 17:1996;169.
15. Han G., Israel M., Seshadri R., Dalton J.T., Sweatman T.W. Pharmacology of N,N-di(n-butyl)adriamycin-14-valerate in the rat. Cancer Chemother Pharmacol. 37:1996;472.
16. Herben V.M., Bokkel Huinink W.W., Beijnen J.H. Clinical pharmacokinetics of topotecan. Clin Pharmacokinet. 31:1996;85.
17. Spencer C.M., Faulds D. Paclitaxel. a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer Drug. 48:1994;794.
18. Jackson R.C., Leopold W.R., Sebolt J.S. Biochemical and experimental chemotherapy studies of the pyrazoloacridines. Proc AACR. 29:1988;536.
19. Brüsselbach S., Nettelbeck D.M., Sedlacek H.H., Müller R. Cell cycle-independent induction of apoptosis by the anti-tumor drug flavopiridol in endothelial cells. Int J Cancer. 77:1998;146.
20. König A., Schwartz G.K., Mohammad R.M., Al-Katib A., Gabrilove J.L. The novel cyclin-dependent inhibitor flavopiridol down-regulated Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines. Blood. 90:1997;4307.
21. Bagchi D., Bagchi M., Hassoun E.A., Kelly J., Stohs S.J. Adriamycin-induced hepatic and myocardial lipid peroxidation and DNA damage, and enhanced excretion of urinary lipid metabolites. Toxicology. 95:1995;1.
22. Yang M., Nazhat N.B., Jiang X., Kelsey S.M., Blake D.R., Newland A.C., Morris C.J. Adriamycin stimulates proliferation of human lymphoblastic leukaemic cells via a mechanism of hydrogen peroxide production. Br J Haematol. 95:1996;339.
23. Parchment R.E., Volpe D.A., LoRusso P.M., Erickson-Miller C.L., Murphy M.J. Jr., Grieshaber C.K. In vitro-in vivo correlation of myelotoxicity of 9-methoxypyrazoloacridine to myeloid and erythroid hematopoietic progenitors from human, murine and canine marrow. J Natl Cancer Inst. 86:1994;273.
24. Rowinsky E.K., Eisenhauer E.A., Chaudhry V. Clinical toxicities encountered with Taxol. Semin Oncol. 20(Suppl 3):1993;1.
25. Greenberg P., Bax I., Mara B., Schrier S. Alterations of granulopoiesis following chemotherapy. Blood. 44:1974;375.
26. Parent-Massin D, Thouvenot D (1993) In vitro study of pesticide hematotoxicity in human and rat progenitors J Pharmacol Toxicol Meth 30:203.
27. Holberg-Petersen M., Rollag H., Beck S., Øverli I., Tjønnfjord G., Abrahamsen T.G., Degré M., Hestdal K. Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitro. Blood. 88:1996;2510.
28. Parchment R.E. Alternative testing systems for evaluating non-carcinogenic, hematologic toxicity. Environ Health Perspect. 106(Suppl 2):1998;541.